
---
title: '恒瑞医药：SHR8554注射液上市许可申请获受理'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=3570'
author: 证券时报网
comments: false
date: Fri, 08 Jul 2022 16:42:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=3570'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600276" style="color: #2f67d1;text-decoration: none;" code="600276" target="_blank">恒瑞医药</a>(600276)7月8日晚间公告，SHR8554注射液上市许可申请获受理。SHR8554注射液适用于术后镇痛治疗。</p>

                  
</div>
            